Literature DB >> 10029626

Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation.

M Müschen1, U Warskulat, T Peters-Regehr, J G Bode, R Kubitz, D Häussinger.   

Abstract

BACKGROUND & AIMS: CD95 (Apo-1/Fas) ligand suppresses inflammatory responses in immune-privileged organs. In this study, modulation of the hepatic CD95 receptor/ligand system by interferon gamma and cyclosporin A was investigated.
METHODS: CD95 receptor and ligand expression were measured at the messenger RNA level by using quantitative reverse-transcription polymerase chain reaction and immunocytochemistry in primary cultures of rat Kupffer cells, hepatocytes, and T lymphocytes. Soluble CD95 in culture supernatants was detected by enzyme-linked immunosorbent assay and apoptosis by the TUNEL method.
RESULTS: Interferon gamma treatment led to an increase in CD95 ligand messenger RNA levels in Kupffer cells followed by an overexpression of the soluble CD95 receptor. Supernatants derived from 24-hour but not from 48-hour interferon gamma-treated Kupffer cells killed lymphocytes by a CD95-dependent mechanism. Cyclosporin A inhibited CD95 ligand expression in Kupffer cells and lymphocyte killing. In liver parenchymal cells, interferon gamma increased messenger RNA levels of the transmembrane CD95 isoform and sensitivity of these cells toward CD95-mediated apoptosis.
CONCLUSIONS: The expression pattern of CD95 receptor and ligand in response to interferon gamma points to a coordinated interplay between Kupffer cells, hepatocytes, and T lymphocytes in which Kupffer cells may regulate programmed cell death of T lymphocytes and hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10029626     DOI: 10.1016/s0016-5085(99)70189-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

1.  Apoptosis in rat spontaneous chronic pancreatis: role of the Fas and Fas ligand system.

Authors:  S B Su; Y Motoo; M J Xie; N Sawabu
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  CD95 ligand expression as a mechanism of immune escape in breast cancer.

Authors:  M Müschen; C Moers; U Warskulat; J Even; D Niederacher; M W Beckmann
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

Review 3.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

4.  Crucial Fas-Fas ligand interaction in spontaneous acceptance of hepatic allografts in mice.

Authors:  Hideaki Uchiyama; Kenji Kishihara; Ryosuke Minagawa; Koji Hashimoto; Keizo Sugimachi; Kikuo Nomoto
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

Review 5.  Cell biology of ischemia/reperfusion injury.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

6.  Involvement of soluble CD95 in Churg-Strauss syndrome.

Authors:  M Müschen; U Warskulat; A Perniok; J Even; C Moers; B Kismet; N Temizkan; D Simon; M Schneider; D Häussinger
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 7.  Role of Kupffer cells in the pathogenesis of liver disease.

Authors:  George Kolios; Vassilis Valatas; Elias Kouroumalis
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

8.  Oxidative stress and benefits of antioxidant agents in acute and chronic hepatitis.

Authors:  Mukaddes Esrefoglu
Journal:  Hepat Mon       Date:  2012-03-28       Impact factor: 0.660

9.  Characterization of chronic HCV infection-induced apoptosis.

Authors:  Abdel-Rahman N Zekri; Abeer A Bahnassy; Mohamed M Hafez; Zeinab K Hassan; Mahmoud Kamel; Samah A Loutfy; Ghada M Sherif; Abdel-Rahman El-Zayadi; Sayed S Daoud
Journal:  Comp Hepatol       Date:  2011-07-23

10.  Immunomodulatory Role of Kupffer Cell in Liver Allografts.

Authors:  Zhaoli Sun; Tatehiko Wada; Sumito Hoshino; Keiichiro Uchikura; Andrew S Klein
Journal:  Comp Hepatol       Date:  2004-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.